SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
Zhang Z, Qiu N, Yin J, Zhang J, Liu H, Guo W, Liu M, Liu T, Chen D, Luo K, Li H, He Z, Liu J, Zheng G.
Zhang Z, et al. Among authors: liu j, liu h, liu m, liu t.
Theranostics. 2020 Mar 4;10(10):4290-4307. doi: 10.7150/thno.41008. eCollection 2020.
Theranostics. 2020.
PMID: 32292495
Free PMC article.